362 related articles for article (PubMed ID: 10531299)
1. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
Zhou Z; Gong Q; January CT
J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
[TBL] [Abstract][Full Text] [Related]
2. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
3. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel.
Furutani M; Trudeau MC; Hagiwara N; Seki A; Gong Q; Zhou Z; Imamura S; Nagashima H; Kasanuki H; Takao A; Momma K; January CT; Robertson GA; Matsuoka R
Circulation; 1999 May; 99(17):2290-4. PubMed ID: 10226095
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block.
Rajamani S; Anderson CL; Anson BD; January CT
Circulation; 2002 Jun; 105(24):2830-5. PubMed ID: 12070109
[TBL] [Abstract][Full Text] [Related]
6. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
7. Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing.
Thomas D; Kiehn J; Katus HA; Karle CA
Cardiovasc Res; 2003 Nov; 60(2):235-41. PubMed ID: 14613852
[TBL] [Abstract][Full Text] [Related]
8. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
Spector PS; Curran ME; Keating MT; Sanguinetti MC
Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
[TBL] [Abstract][Full Text] [Related]
9. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.
Ficker E; Thomas D; Viswanathan PC; Dennis AT; Priori SG; Napolitano C; Memmi M; Wible BA; Kaufman ES; Iyengar S; Schwartz PJ; Rudy Y; Brown AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1748-56. PubMed ID: 11009462
[TBL] [Abstract][Full Text] [Related]
10. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.
Roti EC; Myers CD; Ayers RA; Boatman DE; Delfosse SA; Chan EK; Ackerman MJ; January CT; Robertson GA
J Biol Chem; 2002 Dec; 277(49):47779-85. PubMed ID: 12270925
[TBL] [Abstract][Full Text] [Related]
11. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological rescue of trafficking defective HERG channels formed by coassembly of wild-type and long QT mutant N470D subunits.
Gong Q; Anderson CL; January CT; Zhou Z
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H652-8. PubMed ID: 15072950
[TBL] [Abstract][Full Text] [Related]
13. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.
January CT; Gong Q; Zhou Z
J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1413-8. PubMed ID: 11196567
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
Paulussen A; Raes A; Matthijs G; Snyders DJ; Cohen N; Aerssens J
J Biol Chem; 2002 Dec; 277(50):48610-6. PubMed ID: 12354768
[TBL] [Abstract][Full Text] [Related]
15. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Sanguinetti MC; Jiang C; Curran ME; Keating MT
Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
[TBL] [Abstract][Full Text] [Related]
17. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
18. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects.
Zhou Z; Gong Q; Epstein ML; January CT
J Biol Chem; 1998 Aug; 273(33):21061-6. PubMed ID: 9694858
[TBL] [Abstract][Full Text] [Related]
19. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome.
Ficker E; Dennis AT; Obejero-Paz CA; Castaldo P; Taglialatela M; Brown AM
J Mol Cell Cardiol; 2000 Dec; 32(12):2327-37. PubMed ID: 11113008
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
Smith JL; Reloj AR; Nataraj PS; Bartos DC; Schroder EA; Moss AJ; Ohno S; Horie M; Anderson CL; January CT; Delisle BP
Am J Physiol Cell Physiol; 2013 Nov; 305(9):C919-30. PubMed ID: 23864605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
